Delisting risk
Traws Pharma (TRAW)
Develops oral antivirals for influenza and COVID-19.
$0.5800
Pre-market+0.01 (+1.79%)
At close$0.5698(−3.42%)
Something off on this page? Send us feedback.
Next report
Nov 12, 2026
in 70 days
EPS estimate
−$0.21
Revenue estimate
$2.7M
Fiscal quarter
Q1 FY27
EPSReportedEstimate
Mar '25May '25Aug '25Apr '26May '26Aug '26Aug '26Nov '26
Reported$95.66$2.09−$0.11−$0.71−$0.53−$0.53−$0.16Pending
Estimate−$9.55−$8.04−$8.75−$1.22−$0.92−$0.34−$0.34−$0.21
Surprise+1,101.7%+126.0%+98.7%+42.0%+42.4%−58.2%+52.2%—
RevenueReportedEstimate
Mar '25May '25Aug '25Apr '26May '26Aug '26Aug '26Nov '26
Reported$56.0K$57.0K$2.7M————Pending
Estimate$60.0K$60.0K$60.0K$60.0K$2.7M——$2.7M
Surprise−6.7%−5.0%+4,455.0%—————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.21 | — | — |
| Aug 2026 | −$0.34 | −$0.16 | +52.2% |
| Aug 2026 | −$0.34 | −$0.53 | −58.2% |
| May 2026 | −$0.92 | −$0.53 | +42.4% |
| Apr 2026 | −$1.22 | −$0.71 | +42.0% |
The latest year is open to everyone — the 33 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Apr 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| Mar 2023 | |||
| Dec 2022 | |||
| Aug 2022 | |||
| Jun 2022 | |||
| Dec 2021 | |||
| Jun 2021 | |||
| Dec 2020 | |||
| Jun 2020 | |||
| Dec 2019 | |||
| Jun 2019 | |||
| Dec 2018 | |||
| Jun 2018 | |||
| Dec 2017 | |||
| Jun 2017 | |||
| Dec 2016 | |||
| Jun 2016 | |||
| Dec 2015 | |||
| Jun 2015 | |||
| Dec 2014 | |||
| Jun 2014 | |||
| Dec 2013 | |||
| Jun 2013 | |||
| Dec 2012 | |||
| Jun 2012 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | −$0.21 | — | — | $2.7M | — | — | — |
| Aug 14, 2026 | −$0.34 | −$0.16 | +52.2% | — | — | — | −5.4% |
| Aug 13, 2026 | −$0.34 | −$0.53 | −58.2% | — | — | — | +12.6% |
| May 15, 2026 | −$0.92 | −$0.53 | +42.4% | $2.7M | — | — | −6.4% |
| Apr 15, 2026 | −$1.22 | −$0.71 | +42.0% | $60.0K | — | — | −1.6% |
The latest year is open to everyone — the 33 quarters behind it read with an account. Sign in | |||||||
| Aug 14, 2025 | |||||||
| May 15, 2025 | |||||||
| Mar 31, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 15, 2024 | |||||||
| May 15, 2024 | |||||||
| Apr 1, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 10, 2023 | |||||||
| Mar 16, 2023 | |||||||
| Dec 31, 2022 | |||||||
| Aug 11, 2022 | |||||||
| Jun 30, 2022 | |||||||
| Dec 31, 2021 | |||||||
| Jun 30, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Dec 31, 2016 | |||||||
| Jun 30, 2016 | |||||||
| Dec 31, 2015 | |||||||
| Jun 30, 2015 | |||||||
| Dec 31, 2014 | |||||||
| Jun 30, 2014 | |||||||
| Dec 31, 2013 | |||||||
| Jun 30, 2013 | |||||||
| Dec 31, 2012 | |||||||
| Jun 30, 2012 | |||||||